ID28510A - Formulasi oral yang baru untuk agonis atau antagonis 5-ht4 - Google Patents

Formulasi oral yang baru untuk agonis atau antagonis 5-ht4

Info

Publication number
ID28510A
ID28510A IDW20010318A ID20010318A ID28510A ID 28510 A ID28510 A ID 28510A ID W20010318 A IDW20010318 A ID W20010318A ID 20010318 A ID20010318 A ID 20010318A ID 28510 A ID28510 A ID 28510A
Authority
ID
Indonesia
Prior art keywords
agonists
antagonists
oral formulation
new oral
new
Prior art date
Application number
IDW20010318A
Other languages
English (en)
Inventor
Karel De Bruijn
Gunter Engel
Hans Jurgen Pfannkuche
Michael Thewissen
Christian Vitzling
Othmar Zuger
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27451823&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID28510(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9818340.3A external-priority patent/GB9818340D0/en
Priority claimed from GBGB9823477.6A external-priority patent/GB9823477D0/en
Priority claimed from GBGB9910320.2A external-priority patent/GB9910320D0/en
Priority claimed from GBGB9911059.5A external-priority patent/GB9911059D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ID28510A publication Critical patent/ID28510A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
  • Indole Compounds (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Peptides Or Proteins (AREA)
IDW20010318A 1998-08-21 1999-08-19 Formulasi oral yang baru untuk agonis atau antagonis 5-ht4 ID28510A (id)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9818340.3A GB9818340D0 (en) 1998-08-21 1998-08-21 Organic compounds
GBGB9823477.6A GB9823477D0 (en) 1998-10-27 1998-10-27 Organic compounds
GBGB9910320.2A GB9910320D0 (en) 1999-05-05 1999-05-05 Organic compounds
GBGB9911059.5A GB9911059D0 (en) 1999-05-12 1999-05-12 Organic compounds

Publications (1)

Publication Number Publication Date
ID28510A true ID28510A (id) 2001-05-31

Family

ID=27451823

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20010318A ID28510A (id) 1998-08-21 1999-08-19 Formulasi oral yang baru untuk agonis atau antagonis 5-ht4

Country Status (30)

Country Link
US (4) US20030236183A1 (id)
EP (1) EP1104289B1 (id)
JP (1) JP4048024B2 (id)
KR (1) KR100529659B1 (id)
CN (2) CN1589906A (id)
AT (1) ATE316782T1 (id)
AU (4) AU762829B2 (id)
BG (1) BG65322B1 (id)
BR (1) BR9913135A (id)
CA (1) CA2338794C (id)
CZ (1) CZ300647B6 (id)
DE (1) DE69929703T2 (id)
DK (1) DK1104289T3 (id)
EE (1) EE05054B1 (id)
ES (1) ES2257869T3 (id)
FR (3) FR2782454B1 (id)
HK (1) HK1038179A1 (id)
HR (1) HRP20010123B1 (id)
HU (1) HU228179B1 (id)
ID (1) ID28510A (id)
IL (1) IL141236A0 (id)
IS (1) IS2369B (id)
IT (1) IT1314185B1 (id)
NO (1) NO328756B1 (id)
NZ (1) NZ509832A (id)
PL (2) PL200132B1 (id)
RS (1) RS50104B (id)
SK (1) SK285255B6 (id)
TR (3) TR200100361T2 (id)
WO (1) WO2000010526A2 (id)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002004411A1 (en) 2000-07-07 2002-01-17 The Administrators Of The Tulane Educational Fund Methods for protection of stratified squamous epithelium against injury by noxious substances and novel agents for use therefor
EP1347779A2 (en) * 2000-11-24 2003-10-01 Janssen Pharmaceutica N.V. Use of a triple combination comprising a 5ht3 antagonist, a 5ht4 agonist and a laxative for promoting intestinal lavage
EP1321142A1 (en) * 2001-12-21 2003-06-25 Novartis AG Solid pharmaceutical composition for oral administration of Tegaserod
WO2004075913A1 (ja) 2003-02-28 2004-09-10 Chugai Seiyaku Kabushiki Kaisha タンパク質含有安定化製剤
AU2003222439A1 (en) * 2003-03-25 2004-10-18 Hetero Drugs Limited Novel crystalline forms of tegaserod maleate
GB0307440D0 (en) * 2003-03-31 2003-05-07 Novartis Ag Organic compounds
PE20050253A1 (es) * 2003-07-24 2005-06-03 Novartis Ag Modificaciones estables de maleato de hidrogeno de tegaserod
US8597703B2 (en) 2005-05-23 2013-12-03 Kraft Foods Global Brands Llc Delivery system for active components as part of an edible composition including a ratio of encapsulating material and active component
US8389032B2 (en) 2005-05-23 2013-03-05 Kraft Foods Global Brands Llc Delivery system for active components as part of an edible composition having selected particle size
US8591968B2 (en) 2005-05-23 2013-11-26 Kraft Foods Global Brands Llc Edible composition including a delivery system for active components
US20050112236A1 (en) 2003-11-21 2005-05-26 Navroz Boghani Delivery system for active components as part of an edible composition having preselected tensile strength
US8591973B2 (en) 2005-05-23 2013-11-26 Kraft Foods Global Brands Llc Delivery system for active components and a material having preselected hydrophobicity as part of an edible composition
US8591972B2 (en) 2005-05-23 2013-11-26 Kraft Foods Global Brands Llc Delivery system for coated active components as part of an edible composition
US8591974B2 (en) 2003-11-21 2013-11-26 Kraft Foods Global Brands Llc Delivery system for two or more active components as part of an edible composition
US8216610B2 (en) 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
AU2006317530B2 (en) 2005-11-28 2011-09-01 Imaginot Pty Ltd Oral therapeutic compound delivery system
TR201902233T4 (tr) 2009-10-30 2019-03-21 Ix Biopharma Ltd Hızlı çözünen katı dozaj formu.
JP2014524293A (ja) 2011-08-20 2014-09-22 アドバンスド メディカル バルーンズ ゲーエムベーハー 経肛門的流入カテーテル及び反射作用を調整した排便を断続的に誘引する方法
UA118339C2 (uk) * 2012-09-03 2019-01-10 Біогайа Аб Бактеріальний штам lactobacillus gasseri для лікування порушення моторики кишечнику (варіанти)

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US552398A (en) * 1895-12-31 Riveting-machine
JP2708803B2 (ja) * 1987-09-02 1998-02-04 中外製薬株式会社 持続放出製剤
DE59105613D1 (de) * 1990-08-24 1995-07-06 Spirig Ag Verfahren zur Herstellung von Pellets.
HUT64023A (en) * 1991-03-22 1993-11-29 Sandoz Ag Process for producing aminoguanidine derivatives and pharmaceutical compositions comprising such compounds
US5523289A (en) * 1991-04-15 1996-06-04 Abbott Laboratories Pharmaceutical composition
US20020128172A1 (en) * 1991-12-21 2002-09-12 Smithkline Beecham Plc Use of 5-HT4 modulators for the manufacture of a medicament for the treatment of the bladder diseases
FR2710915B1 (fr) * 1993-10-04 1995-11-24 Synthelabo Dérivés de pipéridine, leur préparation et leur utilisation en thérapeutique.
TW270114B (id) * 1993-10-22 1996-02-11 Hoffmann La Roche
US5399562A (en) * 1994-02-04 1995-03-21 G. D. Searle & Co. Indolones useful as serotonergic agents
JPH0820586A (ja) * 1994-07-05 1996-01-23 Sanwa Kagaku Kenkyusho Co Ltd １−アザビシクロ［３．３．０］オクタン誘導体、その塩及び製法並びに用途
JPH10509982A (ja) * 1994-12-01 1998-09-29 サイバス ファーマシューティカル，インコーポレイティド 高等植物から獲得できる粉末ヒドロコロイドゴムを利用するｎｓａｉｄの導入
US5654320A (en) * 1995-03-16 1997-08-05 Eli Lilly And Company Indazolecarboxamides
IL117438A (en) * 1995-03-16 2001-12-23 Lilly Co Eli Indazolecarboxamides, their preparation and pharmaceutical compositions containing them
JPH09194374A (ja) * 1995-11-14 1997-07-29 Taisho Pharmaceut Co Ltd 消化器疾患治療剤
US5705190A (en) * 1995-12-19 1998-01-06 Abbott Laboratories Controlled release formulation for poorly soluble basic drugs
US5739151A (en) * 1996-07-19 1998-04-14 Sepracor Inc. Method for treating emesis and central nervous system disorders using optically pure (+) norcisapride
FR2753196B1 (fr) * 1996-09-12 1998-10-23 Synthelabo Derives d'indazole tricyclique, leur preparation et leur application en therapeutique
PL197989B1 (pl) * 1997-12-19 2008-05-30 Smithkline Beecham Corp Sposób wytwarzania szybko rozpraszających się tabletek do podawania doustnego, szybko rozpraszający się preparat farmaceutyczny w postaci tabletek i szybko rozpraszająca się, farmaceutycznie dopuszczalna, tabletka do podawania doustnego
US20010014352A1 (en) * 1998-05-27 2001-08-16 Udit Batra Compressed tablet formulation
EP1321142A1 (en) * 2001-12-21 2003-06-25 Novartis AG Solid pharmaceutical composition for oral administration of Tegaserod

Also Published As

Publication number Publication date
FR2799123B1 (fr) 2005-12-02
CA2338794C (en) 2009-01-20
EP1104289A2 (en) 2001-06-06
IS2369B (is) 2008-06-15
BR9913135A (pt) 2001-05-08
ITMI991826A1 (it) 2001-02-19
FR2784899A1 (fr) 2000-04-28
CA2338794A1 (en) 2000-03-02
KR20010079668A (ko) 2001-08-22
SK285255B6 (sk) 2006-09-07
DK1104289T3 (da) 2006-05-15
DE69929703D1 (de) 2006-04-13
FR2782454B1 (fr) 2005-12-02
HK1038179A1 (en) 2002-03-08
KR100529659B1 (ko) 2005-11-21
TR200100361T2 (tr) 2001-06-21
TR200102259T2 (tr) 2002-06-21
WO2000010526A2 (en) 2000-03-02
NO20010863D0 (no) 2001-02-20
SK2432001A3 (en) 2001-09-11
JP2002523351A (ja) 2002-07-30
HUP0103431A2 (hu) 2002-01-28
PL200132B1 (pl) 2008-12-31
YU8701A (sh) 2003-12-31
AU2003248212A1 (en) 2003-10-30
CN1165293C (zh) 2004-09-08
AU2009200403A1 (en) 2009-02-26
US20130158092A1 (en) 2013-06-20
EP1104289B1 (en) 2006-02-01
FR2799123A1 (fr) 2001-04-06
HUP0103431A3 (en) 2002-02-28
HRP20010123A2 (en) 2002-02-28
IT1314185B1 (it) 2002-12-06
AU5623299A (en) 2000-03-14
AU762829B2 (en) 2003-07-03
BG105257A (en) 2001-11-30
FR2782454A1 (fr) 2000-02-25
TR200400187T2 (tr) 2006-11-21
CZ2001619A3 (en) 2001-05-16
IS5851A (is) 2001-01-20
US20120071537A1 (en) 2012-03-22
HRP20010123B1 (en) 2010-11-30
CZ300647B6 (cs) 2009-07-08
BG65322B1 (bg) 2008-02-29
NO328756B1 (no) 2010-05-03
PL194069B1 (pl) 2007-04-30
NO20010863L (no) 2001-03-26
DE69929703T2 (de) 2007-02-22
NZ509832A (en) 2003-11-28
ITMI991826A0 (it) 1999-08-19
IL141236A0 (en) 2002-03-10
WO2000010526A3 (en) 2000-09-08
FR2784899B1 (fr) 2001-08-17
EE200100104A (et) 2002-06-17
ES2257869T3 (es) 2006-08-01
HU228179B1 (en) 2013-01-28
US20030236183A1 (en) 2003-12-25
CN1589906A (zh) 2005-03-09
JP4048024B2 (ja) 2008-02-13
RS50104B (sr) 2009-01-22
US20080075773A1 (en) 2008-03-27
ATE316782T1 (de) 2006-02-15
AU2006200048A1 (en) 2006-02-02
PL346764A1 (en) 2002-02-25
CN1323200A (zh) 2001-11-21
EE05054B1 (et) 2008-08-15

Similar Documents

Publication Publication Date Title
ID28510A (id) Formulasi oral yang baru untuk agonis atau antagonis 5-ht4
ID27504A (id) Formulasi oral baru
MY129356A (en) Electrospun pharmaceutical compositions
ME00520B (me) Levodop/karbidop/entakapon farmaceutski preparat
NO20011721D0 (no) N-aralkylaminotetraliner som ligander for neuropeptid Y Y5 reseptor
HRP20020158B1 (en) Action of synergistic combination
BR9810495A (pt) Composição farmacêutica
DE60019334D1 (de) Antivirale arznei
SE0102843D0 (sv) Stabilized oral pharmaceutical composition containing lodide and lodate and method
DE50005529D1 (de) Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
HU229443B1 (en) Betha-carboline particulate form, pharmaceutical compositions containing it, their preparations and their use
ATE287264T1 (de) Oral anzuwendende buprenorphinhaltige arzneimittel
ATE464878T1 (de) Pharmazeutische zusammensetzung zur nasalen anwendung von fentanyl
SE0001916D0 (sv) Novel formulation
YU87501A (sh) Farmaceutski kompleksi
HRP20010764B1 (en) Prucalopride oral solution
BR0206960A (pt) Composição farmacêutica oral, e, uso de um polìmero de ftalato de hidroxipropilmetilcelulose
SE9902742D0 (sv) New pharmaceutical formultion
TR200003451T2 (tr) Pirimidin-Aminometil-Piridin Türevleri, Hazırlanmaları ve helikobakter bakterinin kontrolünde kullanımları
MY128958A (en) New oral formulation for 5-ht4 agonists or antagonists.
ZA200100289B (en) Use of tiludronic acid and derivatives thereof in poultry for the preparation of a medicinal product for preventing and treating osteoporosis.